Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
How much fat loss is needed for lipoatrophy to become clinically evident?
Podzamczer D, Ferrer E, Martínez E, Del Rio L, Rosales J, Curto J, Ribera E, Barrufet P, Llibre JM, Aranda M; ABCDE Study Team. Podzamczer D, et al. AIDS Res Hum Retroviruses. 2009 Jun;25(6):563-7. doi: 10.1089/aid.2008.0264. AIDS Res Hum Retroviruses. 2009. PMID: 19500014 Free article.
Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
Podzamczer D, Miró JM, Ferrer E, Gatell JM, Ramón JM, Ribera E, Sirera G, Cruceta A, Knobel H, Domingo P, Polo R, Leyes M, Cosin J, Fariñas MC, Arrizabalaga J, Martínez-Lacasa J, Gudiol F. Podzamczer D, et al. Eur J Clin Microbiol Infect Dis. 2000 Feb;19(2):89-95. doi: 10.1007/s100960050436. Eur J Clin Microbiol Infect Dis. 2000. PMID: 10746493 Clinical Trial.
A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
Lopez Bernaldo de Quiros JC, Miro JM, Peña JM, Podzamczer D, Alberdi JC, Martínez E, Cosin J, Claramonte X, Gonzalez J, Domingo P, Casado JL, Ribera E; Grupo de Estudio del SIDA 04/98. Lopez Bernaldo de Quiros JC, et al. Among authors: podzamczer d. N Engl J Med. 2001 Jan 18;344(3):159-67. doi: 10.1056/NEJM200101183440301. N Engl J Med. 2001. PMID: 11172138 Free article. Clinical Trial.
Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy.
Núñez M, Saballs P, Valencia ME, Santos J, Ferrer E, Santos I, Berrocal A, Galindo MJ, Podzamczer D, Gonzlez-Lahoz J; Caelyx/KS Spanish Study Group. Núñez M, et al. Among authors: podzamczer d. HIV Clin Trials. 2001 Sep-Oct;2(5):429-37. doi: 10.1310/700b-9qt3-hgn9-q3fq. HIV Clin Trials. 2001. PMID: 11673818 Clinical Trial.
A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
Podzamczer D, Ferrer E, Consiglio E, Gatell JM, Perez P, Perez JL, Luna E, González A, Pedrol E, Lozano L, Ocaña I, Llibre JM, Casiró A, Aranda M, Barrufet P, Martínez-Lacasa J, Miró JM, Badía X, Casado A, Lupo S, Cahn P, Maños M, Estela J. Podzamczer D, et al. Antivir Ther. 2002 Jun;7(2):81-90. Antivir Ther. 2002. PMID: 12212928 Clinical Trial.
Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine.
Ferrer E, Podzamczer D, Arnedo M, Fumero E, McKenna P, Rinehart A, Pérez JL, Barberá MJ, Pumarola T, Gatell JM, Gudiol F; Combine Study Team. Ferrer E, et al. Among authors: podzamczer d. J Infect Dis. 2003 Feb 15;187(4):687-90. doi: 10.1086/367987. Epub 2003 Jan 29. J Infect Dis. 2003. PMID: 12599088 Clinical Trial.
363 results